• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. NYLON SUTURE; SUTURE, NONABSORBABLE, SYNTHETIC, POLYAMIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. NYLON SUTURE; SUTURE, NONABSORBABLE, SYNTHETIC, POLYAMIDE Back to Search Results
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Fistula (1862); Not Applicable (3189)
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is related to a journal article, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.No specific patient information regarding events has been provided.Attempts are being made to obtain the following information.If further details are received at the later date a supplemental medwatch will be sent.
 
Event Description
It was reported in a journal article entitled: complex bladder-exstrophy-epispadias management: causes of failure of initial bladder closure authors: kouame dibi bertin, kouame yapo guy serge, sounkere moufidath, koffi maxime, odehouri koudou thierry hervé, yaokreh jean baptiste, tembely samba, dieth atafi gaudens, ouattara ossenou, dick ruffin citation: afr j paediatr surg.2014; 11: 334 40 the success of the initial closure of the complex bladder-exstrophy remains a challenge in pediatric surgery.This study describes a personal experience of the causes of failure of the initial closure and operative morbidity during the surgical treatment of bladder-exstrophy complex.A total of 4 patients (3 males and 1 female; age range: 16 days to 7 years old) underwent complex exstrophy-epispadias repair with pelvic osteotomies were included in the study.Of which, 3 patients underwent posterior pelvic osteotomy and 1 patient had anterior innominate osteotomy.During the bladder closure, 1 patient who underwent an anterior innominate osteotomy had closure with vicryl 4-0 sutures.The 3 patients who underwent posterior pelvic osteotomy had closure with pds 4-0 sutures.In all patients, the pubis bones were approximated in the midline with nylon 0 non-absorbable silk suture passed through the two pubic tubercles.This approximation was achieved, while operating aids realized the pressure on the hip bone.The abdominal wall was closed with a polyglecaprone 2-0 on the abdominal rectus fascia, and the skin was closed with separated knot with nylon non-absorbable silk sutures.Epispadias repair was performed with the initial bladder repair and included urethroplasty with repair of the dorsal curvature of the penis.The corpus cavernosum was completely detached from the spongiosum body and urethroplasty was performed on the urethral catheter with pds 6-0 suture.Reported complications included a female patient with a vesico-cutaneous fistula and was treated after the revision surgery.It was reported that the absorbable braided silk may consist of nests of bacteria and be the starting points of the disunity of the bladder and abdominal walls.Bacterial adherence to sutures plays a significant role in the induction of tissue reactions that lead to total disunion of bladder closure.It was concluded that complex bladder-exstrophy management remains a challenge for pediatrics surgeons.The failure of the initial bladder-exstrophy closure may be reduced by a closure with an absorbable monofilament silk and efficient urine drainage by an adequate ureteral stendind.
 
Manufacturer Narrative
(b)(4).Additional information was requested and the following was obtained: yes ethicon products contribute to the complications.When we used the polyglactin (vicryl) only to close the bladder, there is a disruption of the closure because of infections.In my personal experience, the braided silk used to close the bladder, the fascia and the skin, in almost the cases led to complications.Since, we changed and used polyglecaprone, the outcomes of the bladder closure were improve.
 
Manufacturer Narrative
(b)(4).Date sent to the fda: 08/30/2018 (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NYLON SUTURE
Type of Device
SUTURE, NONABSORBABLE, SYNTHETIC, POLYAMIDE
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer Contact
darlene kyle
p.o. box 151, route 22 west
somerville, NJ 08876-0151
9082182792
MDR Report Key7374579
MDR Text Key103603907
Report Number2210968-2018-71683
Device Sequence Number1
Product Code GAR
Combination Product (y/n)N
PMA/PMN Number
K946173
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature,study
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 03/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/27/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received08/28/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-